NOBLEOAK LIFE LIMITED (NOL)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

NOL

NOL - NOBLEOAK LIFE LIMITED

FNArena Sector : Insurance
Year End: June
GICS Industry Group : Insurance
Debt/EBITDA: N/A
Index:

LAST PRICE CHANGE +/- CHANGE % VOLUME

$1.49

04 Sep
2025

-0.020

OPEN

$1.51

-1.32%

HIGH

$1.51

11,973

LOW

$1.49

TARGET
$2.85 91.3% upside
OTHER COMPANIES IN THE SAME SECTOR
AUB . CVW . FCL . GDG . HLI . IAG . MPL . NHF . QBE . SDF . SUN . TWR .
FNARENA'S MARKET CONSENSUS FORECASTS
NOL: 1
Title FY24
Actual		 FY25
Actual		 FY26
Forecast		 FY27
Forecast
EPS (cps) xxx 8.0 21.8 xxx
DPS (cps) xxx 0.0 0.0 xxx
EPS Growth xxx - 26.1% 100.0% xxx
DPS Growth xxx N/A N/A xxx
PE Ratio xxx N/A 6.9 xxx
Dividend Yield xxx N/A 0.0% xxx
Div Pay Ratio(%) xxx N/A N/A xxx

Dividend yield today if purchased 3 years ago: 0.00%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

 0.00

Estimated Dividend Growth
(Average Of Past Three Years)

  %

Amount Invested

 $ 

Tell Me The Dividend After This Many Years
Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2025 FactSet UK Limited. All rights reserved
Title 202020212022202320242025
EPS Basic xxxxxxxxxxxxxxx8.0
DPS All xxxxxxxxxxxxxxx0.0
Sales/Revenue xxxxxxxxxxxxxxx476.4 M
Book Value Per Share xxxxxxxxxxxxxxx95.8
Net Operating Cash Flow xxxxxxxxxxxxxxx58.7 M
Net Profit Margin xxxxxxxxxxxxxxx1.49 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 202020212022202320242025
Return on Capital Employed xxxxxxxxxxxxxxx8.88 %
Return on Invested Capital xxxxxxxxxxxxxxx8.43 %
Return on Assets xxxxxxxxxxxxxxx1.38 %
Return on Equity xxxxxxxxxxxxxxx8.88 %
Return on Total Capital xxxxxxxxxxxxxxx18.12 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx58.6 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 202020212022202320242025
Short-Term Debt xxxxxxxxxxxxxxx1 M
Long Term Debt xxxxxxxxxxxxxxx4 M
Total Debt xxxxxxxxxxxxxxx5 M
Goodwill - Gross xxxxxxxxxxxxxxx0 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx86 M
Price To Book Value xxxxxxxxxxxxxxx1.59

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 202020212022202320242025
Capex xxxxxxxxxxxxxxx0.1 M
Capex % of Sales xxxxxxxxxxxxxxx0.02 %
Cost of Goods Sold xxxxxxxxxxxxxxx-
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx100 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx252 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

1.0

No. Of Recommendations

1
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Shaw and Partners

01/09/2025

1

Buy, High Risk

$2.85

91.28%

According to Shaw and Partners, the highlight of NobleOak Life's FY25 results was a beat at the underlying net profit line and a solid outlook statement, pointing to continued momentum in the business.

Underlying net profit was 5% ahead of forecast, helped by growth in the direct channel. Premium growth is guided to be at least 15% in FY26, and the underlying net profit is expected to grow at least 10%.

The insurer published its first Embedded Value since the IPO, at $2.16/share at the midpoint. The broker notes this compares favourably with the current share price, with the target price accounting for upside potential.

FY26 underlying net profit forecast lifted by 5% and FY27 by 4.8%.

Buy, High Risk. Target unchanged at $2.85.

FORECAST
Shaw and Partners forecasts a full year FY26 dividend of 0.00 cents and EPS of 21.80 cents.
Shaw and Partners forecasts a full year FY27 dividend of 0.00 cents and EPS of 23.70 cents.
Access Stockbroker Research History >
EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

0

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY
Access Extra Coverage Research History >

NOL STOCK CHART

FNArena News on NOL

1
FNArena Corporate Results Monitor – 01-09-2025

Sep 01 2025 - Australia
2
FNArena Corporate Results Monitor – 03-03-2025

Mar 03 2025 - Australia
3
FNArena Corporate Results Monitor – 02-09-2024

Sep 02 2024 - Australia
4
Next Week At A Glance – 22-26 July 2024

Jul 19 2024 - Weekly Reports
5
FNArena Corporate Results Monitor – 29-02-2024

Feb 29 2024 - Australia

Latest Insurance News

1
Insurers To Pamper Shareholders With Buybacks

Jan 24 2025 - Australia
2
IAG Shares Breaking Out

Jan 21 2025 - Technicals
3
ESG Focus: The Little Big Things – 21-11-2024

Nov 21 2024 - ESG Focus
4
New-Look Suncorp Ready To Rumble

Nov 14 2024 - Australia
5
Steadfast’s Long March

Jul 02 2024 - Australia
6
AUB Group Shares Poised For Break-Out

Jun 13 2024 - Technicals
7
SMSFundamentals: Older People Are Life Insurers’ Future Challenge

Oct 26 2023 - SMSFundamentals
8
Australian Insurers And The Weather

Oct 19 2023 - Feature Stories
9
Steadfast Group’s US Entry Full Of Promise

Oct 11 2023 - Australia
10
Pros And Cons Of Insurance Companies

Aug 02 2023 - Australia